Mpm Bioventures 2018, L.p.

Mpm Bioventures 2018, L.p. is listed in filings as otherFormer, 10% Owner at iTeos Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 15, 2025, including sale activity. Recent filings connect the profile to iTeos Therapeutics, Inc. (ITOS) and Entrada Therapeutics, Inc. (TRDA). The current snapshot covers public activity from Dec 12, 2024 to May 15, 2025. Reported amounts are shown as $5.1M to $476.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.